Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BC-1382 is a potent ubiquitin E3 ligase HECTD2 inhibitor that specificly disrupts the HECTD2/PIAS1 interaction(IC50 of 5 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 91.00 | |
5 mg | In stock | $ 223.00 | |
10 mg | In stock | $ 332.00 | |
25 mg | In stock | $ 563.00 | |
50 mg | In stock | $ 812.00 | |
100 mg | In stock | $ 1,130.00 | |
500 mg | In stock | $ 2,260.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 267.00 |
Description | BC-1382 is a potent ubiquitin E3 ligase HECTD2 inhibitor that specificly disrupts the HECTD2/PIAS1 interaction(IC50 of 5 nM). |
In vitro | BC-1382, that targeted HECTD2 and attenuated lipopolysaccharide (LPS)- and Pseudomonas aeruginosa-induced lung inflammation. |
Molecular Weight | 459.56 |
Formula | C23H29N3O5S |
CAS No. | 1013753-99-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (119.68 mM), Sonification is recommended
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BC-1382 1013753-99-5 Others Ubiquitination E1/E2/E3 Enzyme interaction,Anti-inflammatory ligase Inhibitor lung Ubiquitin E1 activating enzyme Ubiquitin activating enzyme inhibit HECTD2 inflammation E3 ligating enzyme BC 1382 BC1382 HECTD2/PIAS1 Ubiquitin ligase Ubiquitin conjugating enzyme E2 conjugating enzyme inhibitor